[19Lys,26Leu]-galparan



[19Lys,26Leu]-galparan

G1GG1W2WW2T3TT3L4LL4N5NN5S6SS6A7AA7G8GG8Y9YY9L10LL10L11LL11G12GG12P13PP13I14II14N15NN15L16LL16K17KK17A18AA18K19KK19A20AA20A21AA21L22LL22A23AA23K24KK24K25KK25L26LL26L27LL27

SMILES None
InChIKey None
Sequence GWTLNSAGYLLGPINLKAKAALAKKLL

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

[19Lys,26Leu]-galparan

G1GG1W2WW2T3TT3L4LL4N5NN5S6SS6A7AA7G8GG8Y9YY9L10LL10L11LL11G12GG12P13PP13I14II14N15NN15L16LL16K17KK17A18AA18K19KK19A20AA20A21AA21L22LL22A23AA23K24KK24K25KK25L26LL26L27LL27

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.